Amylgen is a CRO proposing innovative in vivo models of ageing, psychiatric and neurodegenerative pathologies for the development of new medicines or nutraceuticals.
Amylgen is at your service to provide quick POC for your product as a food supplement for brain health and helps you to substantiate the efficacy of your product by preclinical studies in rodent models
Amylgen brings you preclinical scientific data for your product on
- Brain aging preservation
- Memory enhancement
- Antidepressant /anti anxiety effect
- Protection against Alzheimer’s disease
Amylgen has access to regulatory and clinical partners to aid in the preparation of health claims for EFSA or FDA and the commercialization of your product
Characterization of agonist/antagonist properties of
potential sigma1 receptor ligands in vitro
We developed an original fast-screening in vitro assay based from the observation that the Sig-1R chaperone association to BiP is specifically modulated by agonistic activity of ligands (Meunier & Hayashi, J Pharmacol Exp Ther,2009, Fujimoti et al., Synapse, 2012). By using high affinity ELISA assay, this activity test allows a fast determination of agonist or antagonist property of tested compound.
We need almost 5-8mg of each compound (depending of their MW), and the MSDS of each compound (if possible). We have a preference for solid form but liquid is fine. If compounds are in their liquid form we suggest you to send them frozen.
The price of the assay is directly dependent of the number of compounds you want to test.
Experiments start at reception of your compounds at our facilities and is performed during the month following compounds reception.
Amylgen has not received any reviews.
Amylgen has not received any endorsements.